Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, October 2002, p. 3308-3310, Vol. 46, No. 10
0066-4804/02/$04.00+0 DOI: 10.1128/AAC.46.10.3308-3310.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Robert Eisenthal,2 and Roger Harrison2
Centre for Research in Biomedicine, University of the West of England, Bristol, Bristol BS16 1QY,1 Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath, United Kingdom2
Received 25 March 2002/ Returned for modification 24 May 2002/ Accepted 1 July 2002
| ABSTRACT |
|---|
|
|
|---|
| TEXT |
|---|
|
|
|---|
Recently, the ability of XO to catalyze reactions that generate nitric oxide (NO·) from inorganic nitrite was reported (11, 20). NO· is formed only under anaerobic conditions; when oxygen is present, superoxide is also produced, which reacts with XO-generated NO· to form peroxynitrite (12), a powerful bactericidal agent (6). These observations prompted us to investigate the antibacterial activities of milk, particularly under defined oxygen tensions and with reference to the involvement of nitrite. We used Escherichia coli cells transformed with a plasmid, pLITE27, which carries the luxCDABE operon from Photorhabdus luminescens controlled by the constitutive promoter. Microorganisms expressing the lux operon are able to emit light due to the activity of bacterial luciferase on reduced flavin mononucleotide and a long-chain aldehyde that produces flavin mononucleotide, acid, and blue-green light. Since reduced flavin mononucleotide production depends upon functional electron transport, only metabolically active cells can produce light (4). Therefore, lux operon-dependent bioluminescence is an extremely sensitive, nondestructive, real-time reporter of cell metabolism that has been successfully used to monitor antimicrobial effects (23). This technology confers many advantages over conventional plating techniques and has allowed us to demonstrate, for the first time, bacteriostatic activity for both bovine and human milk that is dependent on XO, low oxygen tensions, and nitrite.
E. coli isolate 16906 was transformed with the luxCDABE operon (23). Cells were grown overnight at 37°C on nutrient agar plates with 50 µg of ampicillin per ml, subcultured into minimal salts medium (8), and grown at 37°C with aeration for 3 h. Aliquots were mixed with an equal volume of 40% glycerol and frozen at -80°C. Before each assay, aliquots were pelleted by centrifugation and resuspended in fresh minimal salts medium at 37°C without glucose or a nitrogen source. Suspension of the cells in the nutrient-deprived medium caused the cells to cease active growth and enter stationary phase, where metabolic activity is at a steady low level. Measured light output was stable, as monitored by a specifically adapted luminometer. This instrument (LKB 1250) was modified so that the reaction cuvette could be continuously supplied with a defined mixture of air and nitrogen, thus allowing accurate control of oxygen tension, which was measured with a Clark-type oxygen electrode. Additions of substrate or inhibitors were made through additional injection ports, effecting minimal disturbance of either oxygen tension or signal output.
The effects of bovine or human milk on the metabolic activity of E. coli were studied under conditions of 0.63% oxygen. This oxygen concentration, known to be optimal for the generation of peroxynitrite by XO (12), had no significant effect on bacterial viability. Following incubation of the cells (3 to 5 min), the enzyme substrates pterin (10 µM) and sodium nitrite (20 mM) were added. Pterin was chosen over both xanthine and hypothine as the reducing substrate in order to avoid complications arising from the peroxynitrite-scavenging activity of urate (12). In the absence of milk, neither pterin nor nitrite had any significant effect on the metabolic activity as assessed by light emission. Fresh bovine or human milk (1 ml) was added to the cuvette and, as can be seen in Fig. 1, a sharp drop in light emission occurred, after which the cells appeared to recover over the next 4 min. However, approximately 5 min after the addition of the milk, a second, slower, and very significant drop in light output was recorded. This drop continued for approximately 5 min, after which a very slow but steady recovery was seen.
|
However, the second large fall in luminescence output was not observed when heat-treated milk was used. Furthermore, the effect was eliminated by the addition of oxypurinol, a specific inhibitor of XO (Fig. 1), and is therefore attributed to this enzyme. Oxypurinol alone appeared to have no effect on bacterial luminescence. The large fall in metabolic activity was also clearly dependent on the presence of nitrite (Fig. 2), which is consistent with the XO-mediated generation of NO·. The latter mechanism was also demonstrated under hypoxic conditions (0.63% oxygen) known to be optimal for XO-catalyzed reduction of nitrite to NO· (12). Such activity falls off rapidly as oxygen tensions increase, and, indeed, experiments conducted under conditions of 20% oxygen showed no significant oxypurinol-dependent impairment of bacterial metabolic activity. This finding argues against a major involvement of hydrogen peroxide (see below).
|
An antibacterial role in the neonatal gut for XO-generated NO·, and potentially peroxynitrite, is plausible for a number of reasons, both spatial and catalytic. XO is located on the outer surface of the milk fat globule membrane, and pathogenic bacteria, with the capacity to target epithelial membranes of the digestive tract, may well bind to similar antigens on the milk fat globule membrane, which is itself of epithelial cell origin (16, 21). This process will not only divert the bacteria from their primary target but will also bring them into intimate contact with XO. Contact of this type will be further promoted by the known affinity of XO for acidic polysaccharides (2), such as occur in many bacterial capsules (15). Therefore, the local concentrations of NO· and peroxynitrite produced in the vicinity of the bacteria could potentially be very high and could account for the antibacterial effects seen.
The catalytic properties of XO are also well suited to its proposed antibacterial function. The optimal pH for anaerobic XO-catalyzed generation of NO· is pH 6 or less (11), much lower than pH 8.8 (which is optimal for aerobic XO activity) and more suited to a role in the digestive tract. It has been suggested that the pH of the neonatal gut generally ranges between pH 4 and pH 6 (25), while others have suggested that the gut of a newborn immediately following birth is relatively alkaline, becoming progressively acidic during the first few days of life (24). Oxygen tensions are also low in the neonatal gut, and therefore the conditions used in the present study are both representative of physiological conditions suggested by others and ideal for NO· generation by XO (25).
Moreover, while the Km value for nitrite in XO-dependent NO· production is in the millimolar region (11), this level can be achieved by enteric bacteria. In anaerobic culture, such bacteria can excrete millimolar levels of nitrite (9, 22) derived from dissimilatory nitrate reductase (7). It is an intriguing thought that, by generating a nitrite-rich microenvironment, enteric bacteria might initiate their own destruction. Finally, it is worth noting that XO activity of human milk, while generally very much lower than that of cows' milk (1), is exceptionally high in the first few weeks postpartum (5). This is precisely the period when antibacterial activity is required in the neonatal gut and when it both coincides with particularly high levels of nitrite (14) and correlates with the highest levels of XO-dependent NO· generation found in human milk (25).
In summary, we have demonstrated antibacterial activity of bovine and human milk that is dependent on XO-catalyzed reduction of nitrite, leading presumably to NO· and, eventually, peroxynitrite. These findings not only contribute significantly to the long-standing question of the physiological significance of XO in milk but are also relevant to the debate concerning the relative merits of breast- and bottle-feeding of infants. While it is well established that formula-fed infants in developing countries suffer from higher levels of gastrointestinal infections than do breast-fed infants (3, 10, 17), the reasons for this are not clear. A possible factor is XO activity, which is known to be lacking in formula feed (25).
| ACKNOWLEDGMENTS |
|---|
We acknowledge help from H. Macdonald. Cows' milk was kindly supplied by Brook Farm, South Gloucester, United Kingdom.
| FOOTNOTES |
|---|
Present address: School of Biological Sciences, University of Manchester, Manchester M13 9PT, United Kingdom. ![]()
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |